Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Pharma
BMS accentuates the positive after Cobenfy trial flop
On the heels of a clinical setback for BMS' schizophrenia newcomer Cobenfy, the company has served up mixed results for 2025's first quarter.
Fraiser Kansteiner
Apr 24, 2025 11:31am
BMS' schizophrenia drug stumbles in blow to blockbuster plan
Apr 23, 2025 10:35am
Top 20 pharma companies by 2024 revenue
Apr 21, 2025 3:00am
BMS' Camzyos falls short in bid to widen eligible patient pool
Apr 15, 2025 11:42am
BMS follows Roche, AstraZeneca into first-line liver cancer
Apr 11, 2025 1:53pm
Court dismisses case against BMS' patent protection of Pomalyst
Apr 9, 2025 11:32am
